Byondis
Bram Kamps is a skilled DSP Research Scientist at Byondis, where the focus involves developing the purification process of monoclonal antibodies since June 2009. Prior experience includes serving as a 1st Biotechnologisch Laboratorium Assistent at Organon, where work concentrated on the downstream process of a recombinant hormone for in vitro fertilization and the development of analytical assays from November 2005 to May 2009. Bram's background also features a role as a Research Technician at Radboud University Nijmegen, engaging in small heat shock protein research, and prior positions at Wageningen UR and ETH Zurich focused on DNA sequencing and protein purification, respectively. Bram holds a Bachelor of Sciences in Biochemistry from HAN University of Applied Sciences, earned from 1996 to 2000.
This person is not in any teams
This person is not in any offices
Byondis
1 followers
With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs. Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves: • Next generation antibody-drug conjugates (ADCs), including proprietary linker-drug (LD) technology to generate multiple ADC candidates targeting different indications • Site-specific conjugation technology • Monoclonal antibodies (mAbs) • Highly selective, disease-targeting small molecules The success of our company fully depends on our people. To them, we aim to provide a fair, open and inspiring working environment, where there is room for ambition, entrepreneurship and new initiatives leading to new medicines that save and transform patients’ lives.